These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3815906)

  • 1. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis.
    Ljungberg B; Blombäck M; Johnsson H; Lins LE
    Clin Nephrol; 1987 Jan; 27(1):31-5. PubMed ID: 3815906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
    Ljungberg B; Jacobson SH; Lins LE; Pejler G
    Clin Nephrol; 1992 Aug; 38(2):97-100. PubMed ID: 1325310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of fragmin in program hemodialysis of patients with terminal chronic renal failure].
    Kozlova TV; Shilo VIu; Denisov AIu
    Klin Med (Mosk); 2005; 83(9):45-9. PubMed ID: 16279040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low molecular heparin fraction as an anticoagulant during hemodialysis.
    Ljungberg B
    Clin Nephrol; 1985 Jul; 24(1):15-20. PubMed ID: 4017295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: a comparison of administration by single-dose and by infusion.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1983 Feb; 19(2):82-6. PubMed ID: 6839556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
    Lane DA; Ireland H; Flynn A; Anastassiades E; Curtis JR
    Nephrol Dial Transplant; 1986; 1(3):179-87. PubMed ID: 2955253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E; Lane DA; Ireland H; Flynn A; Curtis JR
    Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
    Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
    Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan.
    Suzuki T; Ota K; Naganuma S; Koshikawa S; Hirasawa Y; Nakagawa S; Otsubo O; Akizawa T
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():46-54. PubMed ID: 1962904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B; Asaba H; Dawidson S; Wilhelmsson S; Bergström J
    Clin Nephrol; 1981 Mar; 15(3):135-42. PubMed ID: 7273488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session.
    Brunet P; Simon N; Opris A; Faure V; Lorec-Penet AM; Portugal H; Dussol B; Berland Y
    Am J Kidney Dis; 2008 May; 51(5):789-95. PubMed ID: 18436089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
    Ireland H; Lane DA; Flynn A; Pegrum AC; Curtis JR
    Thromb Haemost; 1988 Apr; 59(2):240-7. PubMed ID: 2838924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis.
    Ryan KE; Lane DA; Flynn A; Shepperd J; Ireland HA; Curtis JR
    Thromb Haemost; 1991 Sep; 66(3):277-82. PubMed ID: 1745997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients].
    Xiao Q; Sun XF; Zhang D; Ma ZF; Wu MG; Wang H; Chen XM
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):187-91. PubMed ID: 20356555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of anticoagulation efficacy and clinical safety between imported and domestically manufactured low-molecular-weight heparin during hemodialysis.
    Liu ZQ; Wang L
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):942-3. PubMed ID: 12377628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
    Dieval J; Morinière P; Roussel B; Bayrou B; Fournier A; Delobel J
    J Mal Vasc; 1987; 12 Suppl B():114-8. PubMed ID: 2834482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure.
    Lane DA; Ireland H; Tew CJ; Flynn A; Curtis JR
    Acta Chir Scand Suppl; 1988; 543():101-4. PubMed ID: 2847457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective assessment of heparin requirements for hemodialysis in humans.
    Ireland H; Lane DA; Curtis JR
    J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.